| 阿立哌唑治疗精神分裂症的临床研究 |
| |
| 引用本文： | 李粤巍.阿立哌唑治疗精神分裂症的临床研究[J].中国民康医学,2011,23(8):927-928. |
| |
| 作者姓名： | 李粤巍 |
| |
| 作者单位： | 辽宁省沈阳市铁西区精神卫生中心,辽宁,沈阳,110141 |
| |
| 摘 要： | 目的:评价阿立哌唑治疗精神分裂症的疗效及不良反应。方法:将64例精神分裂症患者随机分为两组,分别给予阿立哌唑与利培酮治疗8周。采用阳性与阴性症状量表(PANSS)、治疗中出现的症状量表(TESS)评定疗效及不良反应。结果:阿立哌唑组显效率78.1%,利培酮组为75.0%,两组疗效比较差别无统计学意义(P<0.05)。利培酮组锥体外系反应稍高于阿立哌唑组。结论:阿立哌唑与利培酮疗效相似,锥体外系反应比利培酮少,是有效、安全的抗精神病药物。
|
| 关 键 词： | 阿立哌唑 利培酮 精神分裂症 |
Clinical analysis of Aripiprazole in the treatment of schizophrenia |
| |
| LI Yue-wei.Clinical analysis of Aripiprazole in the treatment of schizophrenia[J].medical journal of chinese peoples health,2011,23(8):927-928. |
| |
| Authors: | LI Yue-wei |
| |
| Institution: | LI Yue-wei(Shenyang Tiexi district mental health center,Shenyang 110141,China) |
| |
| Abstract: | Objective:To observe the adverse events and efficacy of Aripiprazole in the treatment of schizophrenia.Methods:Sixty-four cases of schizophrenia were randomly divided into Aripiprazole group and Risperidone group.The course of treatments was 8 weeks.The therapeutic effects were evaluated by positive and negative symptom scale(PANSS),and side effects were assessed by treatment emergent symptom scale(TESS).Results:The rates of marked improvement in Aripiprazole group and Risperidone group were 78.1% and 75.0%... |
| |
| Keywords: | Aripiprazole Risperidone Schizophrenia |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
